Abbott Laboratories
ABT
HK$1,036
Share price
-1.18%
Change (1 day)
27.41%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total assets
Total assets on the balance sheet as of March 2025 : HK$639.34 Billion
According to Abbott Laboratories's latest financial reports the company's total assets are HK$639.34 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Abbott Laboratories - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | HK$632.05 B | 10.54% |
| 2023-12-31 | HK$571.80 B | -1.68% |
| 2022-12-31 | HK$581.60 B | -0.81% |
| 2021-12-31 | HK$586.34 B | 4.26% |
| 2020-12-31 | HK$562.40 B | 6.37% |
| 2019-12-31 | HK$528.71 B | 0.51% |
| 2018-12-31 | HK$526.02 B | -11.7% |
| 2017-12-31 | HK$595.73 B | 45.87% |
| 2016-12-31 | HK$408.40 B | 27.75% |
| 2015-12-31 | HK$319.69 B | 0.02% |
| 2014-12-31 | HK$319.62 B | -4.04% |
| 2013-12-31 | HK$333.07 B | -36.09% |
| 2012-12-31 | HK$521.15 B | 11.32% |
| 2011-12-31 | HK$468.16 B | -0.69% |
| 2010-12-31 | HK$471.39 B | 15.99% |
| 2009-12-31 | HK$406.42 B | 23.99% |
| 2008-12-31 | HK$327.79 B | 5.86% |
| 2007-12-31 | HK$309.64 B | 10.05% |
| 2006-12-31 | HK$281.37 B | 24.54% |
| 2005-12-31 | HK$225.94 B | 1.07% |
| 2004-12-31 | HK$223.55 B | 10.76% |
| 2003-12-31 | HK$201.83 B | 6.69% |
| 2002-12-31 | HK$189.18 B | 4.14% |
| 2001-12-31 | HK$181.65 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | HK$1.520 T | 137.78% | 🇺🇸 USA |
 Pfizer PFE | HK$1.632 T | 155.41% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$777.44 B | 21.60% | 🇺🇸 USA |
 Hologic HOLX | HK$67.07 B | -89.51% | 🇺🇸 USA |
 Medtronic MDT | HK$719.66 B | 12.56% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | HK$725.52 B | 13.48% | 🇺🇸 USA |
 Boston Scientific BSX | HK$315.08 B | -50.72% | 🇺🇸 USA |
 AstraZeneca AZN | HK$834.05 B | 30.46% | 🇬🇧 UK |
 Novartis NVS | HK$784.50 B | 22.71% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | HK$615.70 B | -3.70% | 🇬🇧 UK |